Matrixx Initiatives
Bridgewater
About Matrixx Initiatives
Matrixx Initiatives has been engaged in the development and marketing of better ways to feel better through over-the-counter health care products that utilize innovative drug delivery systems for over 20 years. Matrixx Initiatives manufactures and markets Zicam® brand homeopathic and allopathic OTC products, including its clinically proven ZICAM® Cold Remedy Nasal Spray and Swab, ZICAM® Cold Remedy RAPIDMELTS®, ZICAM® Cold Remedy Oral Mist™, ZICAM® Cold Remedy Medicated Fruit Drops, ZICAM® Cold Remedy Ultra Crystals and ZICAM® Cold Remedy Lozenges. Matrixx products also include ZICAM® Cold Remedy Relief for Kids, ZICAM® Allergy Relief Spray and Swab, ZICAM® Extreme Congestion Relief and ZICAM® Intense Sinus Relief. For more information regarding Matrixx products, please visit www.zicam.com.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $80.0M
- Funding stage: M&A
- Last round: Debt Financing (Aug 2013)
- Website: matrixxinc.com
- Phone: +1 602-385-8888
Industries & Categories
Biotechnology, Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/matrixx-initiatives-2428358 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.